Published Apr 13, 2020

#324 Gvoke Glucagon

Join Scott Benner as he delves into the career journey and innovative impact of Paul Edick, CEO of Xeris, with a focus on the revolutionary development of Gvoke, a groundbreaking liquid stable glucagon for severe hypoglycemia, and the evolving landscape of patient-centered diabetes management.
Episode Highlights
Juicebox Podcast: Type 1 Diabetes logo

Popular Clips

Questions from this episode

Episode Highlights

  • Patient-Centered

    emphasizes the importance of patient-centered healthcare, focusing on products that positively impact patients' lives and reduce overall costs. He believes that understanding patient needs is crucial in navigating the complex healthcare landscape, which is increasingly driven by financial factors rather than care 1. shares his approach to building a successful company, highlighting the importance of behavior and customer service over financial goals 2.

    If I'm going to build a company, it's going to be around products that can change healthcare for the better.

    ---

    This philosophy is reflected in his leadership at Xeris, where the focus is on creating meaningful solutions for patients.

       

    Misconceptions

    Misconceptions about diabetes treatment, particularly regarding glucagon, are prevalent. shares a personal story highlighting the challenges of using traditional glucagon during emergencies, emphasizing the need for more accessible solutions 3. addresses these misconceptions, noting that glucagon should be used before critical stages of hypoglycemia, not just as a last resort 4.

    The current form factor is almost impossible to use. Only about 20% of those people actually have glucagon, when almost all of them should have it.

    ---

    He advocates for innovations like Gvoke, which offer a more user-friendly and effective approach to managing severe hypoglycemia.

       

    Parenting

    Parenting a child with diabetes presents unique challenges, as recounts a harrowing experience with his daughter. He stresses the importance of simplifying emergency treatments like glucagon to alleviate parental stress during crises 5. discusses ongoing innovations in glucagon delivery, such as continuous infusion and mini-dosing, which aim to improve safety and convenience for families 6.

    It's a rare individual that is calm in a crisis.

    ---

    These advancements reflect a commitment to making diabetes management more manageable for parents and caregivers.

Related Episodes